Events February 23, 2005 - February 24, 2005

BIO CEO & Investor Conference 2005

Goodwin Procter is a sponsor of this conference that will include 24 focus sessions addressing important therapeutic and technology topics with industry experts and relevant company executives; 120 individual company presentations; roundtables and plenary sessions on key business issues and industry trends; and one-on-one meetings arranged for investors with corporate management. Sharon Webb will moderate "Drug Development: Finding Gold in Older Drugs." Kingsley Taft  will speak on the "Biotechnology Company Strategies for Value Creation - How Do They Really Stack Up?" panel, and Larry Wittenberg  will speak on the "Beyond the IPO: Follow-on Financing Trends" panel.
http://ceo.bio.org/opencms/ceo2005/index.jsp